Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation Trial in the Ambulance (Mobile Stroke Unit—TASTE-A): protocol for a prospective randomised, open-label, blinded endpoint, phase II superiority trial of tenecteplase versus alteplase for ischaemic stroke patients presenting within 4.5 hours of symptom onset to the mobile stroke unit
Andrew Bivard, Henry Zhao, Skye Coote, Bruce Campbell, Leonid Churilov, Nawaf Yassi, Bernard Yan, Michael Valente, Angelos Sharobeam, Anna Balabanski, Angela Dos Santos, Felix Ng, Francesca Langenberg, Michael Stephenson, Karen Smith, Steve Bernard, Vincent Thijs, Geoffrey Cloud, Philip Choi, Henry Ma, Tissa Wijeratne, Chushuang Chen, Liudmyla Olenko, Stephen M Davis, Geoffrey A Donnan, Mark Parsons
BMJ Open Apr 2022, 12 (4) e056573; DOI: 10.1136/bmjopen-2021-056573